A reduction in both visceral and subcutaneous fats contributes to increased adiponectin by lifestyle intervention in the Diabetes Prevention Program
- 1 October 2014
- journal article
- research article
- Published by Springer Nature in Acta Diabetologica
- Vol. 52 (3) , 625-628
Abstract
Adiponectin, an insulin-sensitizing adipokine, confers protection against type 2 diabetes. Although adiponectin is secreted exclusively from fat, contributions of visceral adipose tissue (VAT) versus subcutaneous adipose tissue (SAT) to adiponectin levels have not been fully understood. We aimed to examine correlations between changes in VAT and SAT volumes and changes in adiponectin levels.Keywords
This publication has 5 references indexed in Scilit:
- Adiponectin, Change in Adiponectin, and Progression to Diabetes in the Diabetes Prevention ProgramDiabetes, 2008
- Body Size and Shape Changes and the Risk of Diabetes in the Diabetes Prevention ProgramDiabetes, 2007
- Adiponectin and adiponectin receptors in insulin resistance, diabetes, and the metabolic syndromeJournal of Clinical Investigation, 2006
- Adiponectin and protection against type 2 diabetes mellitusThe Lancet, 2003
- Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or MetforminNew England Journal of Medicine, 2002